GlaxoSmithKline and Gilead to face off at HIV meeting next week

LONDON (Reuters) - GlaxoSmithKline and Gilead Sciences will vie for business in treating HIV patients next week when both companies unveil clinical trial results at a medical meeting in Seattle.